Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 1
1993 7
1994 5
1995 9
1996 2
1997 8
1998 8
1999 12
2000 11
2001 16
2002 26
2003 17
2004 26
2005 32
2006 19
2007 30
2008 26
2009 46
2010 40
2011 30
2012 39
2013 71
2014 75
2015 81
2016 86
2017 94
2018 89
2019 70
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

871 results
Results by year
Filters applied: . Clear all
Page 1
GATA3 regulates FLG and FLG2 expression in human primary keratinocytes.
Zeitvogel J, Jokmin N, Rieker S, Klug I, Brandenberger C, Werfel T. Zeitvogel J, et al. Sci Rep. 2017 Sep 19;7(1):11847. doi: 10.1038/s41598-017-10252-x. Sci Rep. 2017. PMID: 28928464 Free PMC article.
Barakat syndrome revisited.
Barakat AJ, Raygada M, Rennert OM. Barakat AJ, et al. Am J Med Genet A. 2018 Jun;176(6):1341-1348. doi: 10.1002/ajmg.a.38693. Epub 2018 Apr 16. Am J Med Genet A. 2018. PMID: 29663634 Review.
Divergent lncRNA GATA3-AS1 Regulates GATA3 Transcription in T-Helper 2 Cells.
Gibbons HR, Shaginurova G, Kim LC, Chapman N, Spurlock CF 3rd, Aune TM. Gibbons HR, et al. Front Immunol. 2018 Oct 29;9:2512. doi: 10.3389/fimmu.2018.02512. eCollection 2018. Front Immunol. 2018. PMID: 30420860 Free PMC article.
Male Breast Cancer.
Serdy KM, Leone JP, Dabbs DJ, Bhargava R. Serdy KM, et al. Am J Clin Pathol. 2017 Jan 1;147(1):110-119. doi: 10.1093/ajcp/aqw207. Am J Clin Pathol. 2017. PMID: 28171879
The role of GATA3 in breast carcinomas: a review.
Asch-Kendrick R, Cimino-Mathews A. Asch-Kendrick R, et al. Hum Pathol. 2016 Feb;48:37-47. doi: 10.1016/j.humpath.2015.09.035. Epub 2015 Oct 28. Hum Pathol. 2016. PMID: 26772397 Review.
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.
Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, Zhang W, Li Y, Dave BJ, Nairism├Ągi ML, Greiner TC, Vose J, Weisenburger DD, Lachel C, Wang C, Fu K, Stevens JM, Lim ST, Ong CK, Gascoyne RD, Missiaglia E, Lemonnier F, Haioun C, Hartmann S, Pedersen MB, Laginestra MA, Wilcox RA, Teh BT, Yoshida N, Ohshima K, Seto M, Rosenwald A, Ott G, Campo E, Rimsza LM, Jaffe ES, Braziel RM, d'Amore F, Inghirami G, Bertoni F, de Leval L, Gaulard P, Staudt LM, McKeithan TW, Pileri S, Chan WC, Iqbal J. Heavican TB, et al. Blood. 2019 Apr 11;133(15):1664-1676. doi: 10.1182/blood-2018-09-872549. Epub 2019 Feb 19. Blood. 2019. PMID: 30782609 Free PMC article.
GATA3 in Breast Cancer: Tumor Suppressor or Oncogene?
Takaku M, Grimm SA, Wade PA. Takaku M, et al. Gene Expr. 2015;16(4):163-8. doi: 10.3727/105221615X14399878166113. Gene Expr. 2015. PMID: 26637396 Free PMC article. Review.
GATA3 induces human T-cell commitment by restraining Notch activity and repressing NK-cell fate.
Van de Walle I, Dolens AC, Durinck K, De Mulder K, Van Loocke W, Damle S, Waegemans E, De Medts J, Velghe I, De Smedt M, Vandekerckhove B, Kerre T, Plum J, Leclercq G, Rothenberg EV, Van Vlierberghe P, Speleman F, Taghon T. Van de Walle I, et al. Nat Commun. 2016 Apr 6;7:11171. doi: 10.1038/ncomms11171. Nat Commun. 2016. PMID: 27048872 Free PMC article.
871 results
Jump to page
Feedback